EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms.

Moon Jung ChoiKang Chan ChoiDo Hyun LeeHwa Yeon JeongSeong Jae Kang Min Woo KimIn Ho JeongYoung Myoung YouJin Suk LeeYeon Kyung LeeChan Su ImYong Serk Park

Published in: Nanotechnology, science and applications (2022)

These results suggest that the clinical application of biocompatible cell membrane-derived nanocarriers could be facilitated by functionalization with macrophage-avoiding CD47 and tumor-targeting antibodies.

Keyphrases

cancer therapy
drug delivery
drug release
adipose tissue
nk cells
ionic liquid